IL54264A - Pharmaceutical compositions comprising 1,3-bis(2-carboxychromon-5-yloxy)propan-2-ol and h1 anti-histamines - Google Patents

Pharmaceutical compositions comprising 1,3-bis(2-carboxychromon-5-yloxy)propan-2-ol and h1 anti-histamines

Info

Publication number
IL54264A
IL54264A IL54264A IL5426478A IL54264A IL 54264 A IL54264 A IL 54264A IL 54264 A IL54264 A IL 54264A IL 5426478 A IL5426478 A IL 5426478A IL 54264 A IL54264 A IL 54264A
Authority
IL
Israel
Prior art keywords
carboxychromon
histamines
yloxy
propan
bis
Prior art date
Application number
IL54264A
Other languages
English (en)
Other versions
IL54264A0 (en
Original Assignee
Fisons Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fisons Ltd filed Critical Fisons Ltd
Publication of IL54264A0 publication Critical patent/IL54264A0/xx
Publication of IL54264A publication Critical patent/IL54264A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/36—Radicals substituted by singly-bound nitrogen atoms
    • C07D213/38—Radicals substituted by singly-bound nitrogen atoms having only hydrogen or hydrocarbon radicals attached to the substituent nitrogen atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/22—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IL54264A 1977-03-17 1978-03-13 Pharmaceutical compositions comprising 1,3-bis(2-carboxychromon-5-yloxy)propan-2-ol and h1 anti-histamines IL54264A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB11390/77A GB1582362A (en) 1977-03-17 1977-03-17 Cromoglycic acid salts and compositions

Publications (2)

Publication Number Publication Date
IL54264A0 IL54264A0 (en) 1978-06-15
IL54264A true IL54264A (en) 1984-01-31

Family

ID=9985349

Family Applications (1)

Application Number Title Priority Date Filing Date
IL54264A IL54264A (en) 1977-03-17 1978-03-13 Pharmaceutical compositions comprising 1,3-bis(2-carboxychromon-5-yloxy)propan-2-ol and h1 anti-histamines

Country Status (18)

Country Link
JP (1) JPS53115823A (enExample)
AU (1) AU516337B2 (enExample)
BE (1) BE864837A (enExample)
CA (1) CA1113862A (enExample)
CH (1) CH628517A5 (enExample)
DE (1) DE2810974A1 (enExample)
DK (1) DK113378A (enExample)
FI (1) FI780782A7 (enExample)
FR (1) FR2383937A1 (enExample)
GB (1) GB1582362A (enExample)
IE (1) IE46581B1 (enExample)
IL (1) IL54264A (enExample)
LU (1) LU79253A1 (enExample)
NL (1) NL7802869A (enExample)
NO (1) NO152297C (enExample)
NZ (1) NZ186712A (enExample)
SE (1) SE444939B (enExample)
ZA (1) ZA781520B (enExample)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA812811B (en) * 1980-04-30 1982-06-30 Fisons Ltd Mixtures and salts of beta-2 selective bronchodilators with cromoglycic acid and salts thereof
EP0040489A1 (en) * 1980-05-17 1981-11-25 FISONS plc Mixtures, salts, packages and pharmaceutical compositions containing 5-(2-hydroxypropoxy)-4-oxo-8-propyl-4H-1-benzopyran-2-carboxylic acid or a derivative thereof and an H2 receptor antagonist antihistamine

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL44022A0 (en) * 1973-01-23 1974-05-16 Fisons Ltd Novel salts of anti-inflammatory quinoline derivatives,their preparation and pharmaceutical compositions containing them
FR2217004A1 (en) * 1973-02-15 1974-09-06 Aries Robert Sedatives and bronchodilatories - i.e. salts of 1,3-bis(2-carboxychromon-5-yloxy)propanes with 3-hydroxy-2-hydroxymethyl pyridines
FR2230358A2 (en) * 1973-05-25 1974-12-20 Fisons Ltd Cromoglycate contg. solns. - contg. a second therapeutically active cpd. e.g. an antihistamine
DE2535258C2 (de) * 1974-08-10 1993-06-03 Fisons Plc, Ipswich, Suffolk Inhalierbares Medikament in Pelletform

Also Published As

Publication number Publication date
NL7802869A (nl) 1978-09-19
AU516337B2 (en) 1981-05-28
GB1582362A (en) 1981-01-07
NO152297C (no) 1985-09-04
NZ186712A (en) 1979-12-11
BE864837A (fr) 1978-09-13
LU79253A1 (fr) 1978-10-17
CH628517A5 (en) 1982-03-15
NO152297B (no) 1985-05-28
IL54264A0 (en) 1978-06-15
JPS53115823A (en) 1978-10-09
NO780935L (no) 1978-09-19
DE2810974A1 (de) 1978-09-21
SE444939B (sv) 1986-05-20
CA1113862A (en) 1981-12-08
DE2810974C2 (enExample) 1988-07-21
FI780782A7 (fi) 1978-09-18
IE46581B1 (en) 1983-07-27
FR2383937B1 (enExample) 1982-07-23
IE780530L (en) 1978-09-17
DK113378A (da) 1978-09-18
AU3427278A (en) 1979-09-20
FR2383937A1 (fr) 1978-10-13
SE7803069L (sv) 1978-09-18
ZA781520B (en) 1979-04-25

Similar Documents

Publication Publication Date Title
NZ186197A (en) 3,4,5-trimethoxybenzene derivatives and pharmaceutical compositions
IL56155A (en) Substituted alkanoylanilide derivatives,their preparation and pharmaceutical compositions comprising them
IL55930A0 (en) 1,9-dihydroxyoctahydrophenanthrenes, pharmaceutical compositions containing them and intermediates for their preparation
ZA783829B (en) 1-acyl-2-cyanoaziridines,processes for their preparation and pharmaceutical compositions thereof
DE3064582D1 (en) 5,6,7-trinor-4,8-inter-m-phenylene pgi2 derivatives and pharmaceutical compositions containing them
IL56076A (en) 2 alpha-cyano-4 alpha,5 alpha-epoxyandrostanes,their preparation and pharmaceutical compositions containing them
NZ188974A (en) 1,2,3,4,6,7,12,12b-octahydro(2,3-aquinolizine derivatives and pharmaceutical compositions
PH18415A (en) Flavan derivatives,pharmaceutical compositions and use thereof
IL54337A (en) 1-aminoindanes, their preparation and pharmaceutical compositions comprising them
NZ187789A (en) 1,3-diazacyclopent-2-eno (2,1-b)(1-thia-o-azacycloalkanes)and pharmaceutical compositions
IL62744A (en) Pharmaceutical compositions comprising mixtures of a 1,3-bis(2-carboxychromon-5-yloxy)propan-2-ol derivative and a bronchodilator
NZ184187A (en) W-nor-aromatic-13,14-dehydro-prostaglandins pharmaceutical and veterinary compositions intermediates
NZ189300A (en) 3-aminoalkyl-thiazolidine-2,4-diones and pharmaceutical compositions
IL55894A (en) 1-alkylenedithia (or oxathia) benzyl-4-heteroaryl-piperazine derivatives,their preparation and pharmaceutical compositions containing them
NZ186760A (en) 11hpyrido (2,1-b) quinazolin-11-ones and pharmaceutical compositions
IL56167A (en) Antiviral pharmaceutical compositions comprising 8-aminoalkyltetracyclononane derivatives,certain such novel compounds and their preparation
IL54576A0 (en) New chromene derivatives, their preparation and pharmaceutical compositions containing them
IL53904A (en) -phenyltolyl azacycloalkane or azacycloalkene derivatives,their preparation and pharmaceutical compositions comprising them
NZ190412A (en) 2,4-dichloro-a-(n-imidazolyl-methyl)-dibenzyl ethers and pharmaceutical compositions
AU523616B2 (en) 1,3-bis (2-carboxychromon-5-yloxy)-2-hydroxypropane formulation
EP0004529A3 (en) Arylaminoimidazoline derivatives, their preparation, their analgetic application and pharmaceutical formulations
IL54899A (en) Pyridazinylhydrazones,their preparation and pharmaceutical compositions containing them
IL53674A (en) 3-(4-phenylpiperazinyl or 4-phenylpiperidyl) o-propyloximes,their preparation and pharmaceutical compositions comprising them
IL54956A0 (en) A novel benzoisothiazolone,its preparation and pharmaceutical compositions containing it
DE3061280D1 (en) N,n-disubstituted-aminomethyl-phenylethanolamines and pharmaceutical formulations thereof

Legal Events

Date Code Title Description
KB Patent renewed